logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-40. Treatment Prevalence in 2006: proportion of injectors by primary drug (excluding cannabis) among treated clients in 2006 in nine countries (first treatment incidence, total treatment incidence, total treatment prevalence)

Primary drugFTI = First Treatment incidence TTI = Total Treatment incidenceTRP = Total Prevalence
% clients by primary drug% of injectorsNo of injectors by primary drug% clients by primary drug% of injectorsNo of injectors by primary drug% clients by primary drug% of injectorsNo of injectors by primary drug
Opioids37.948.2103124849.62118959.363.497753
Cocaine21.28.5102018.67.8128515.65.72326
Stimulants (other than cocaine)7.250.420527.161.438673.847.54669
Hypnotics and sedatives2.61.8271.24.8512.43.6223
Other substances3.15.7771.9111132.6371285

Notes:

 The countries supplying data are: BG, CZ, FR, HU, IT, LV, MT, NL, AU. 

 FTI: First Treatment Incidence = First Treatments in Life. 

 TTI: Total Treatment Incidence = First Treatments in Life + Repeated Treatments. 

 TRP: Total Prevalence = First Treatments in Life + Repeated Treatments + Continuous Treatments. 

 Other substances include: volatile/inhalants + hallucinogens +other substances. 

 Cannabis is excluded 

Sources:

 2007 Reitox national reports - Table TDI by centre type.  

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008